Papua New Guinea

For nearly two decades, FHI 360 has been working with local partners to address HIV and AIDS, tuberculosis, and gender-based violence in Papua New Guinea. We’re building strong, enduring networks and mobilizing those relationships to improve the health and well-being of people throughout the country.

Through the U.S. Agency for International Development (USAID) HIV Support in Papua New Guinea project, FHI 360 is working to improve HIV testing, expand treatment coverage for people living with HIV and prevent HIV transmission. The project has introduced innovative HIV care models, supported sustainable prevention interventions, strengthened data collection and use for decision-making, and supported the development of key policies — including guidelines for HIV testing and treatment and clinical services for gender-based violence.

In response to the COVID-19 pandemic, the Meeting Targets and Maintaining Epidemic Control (EpiC) project supported the rollout of Papua New Guinea’s national vaccination plan, prepared frontline health workers to administer the vaccine, tracked the adverse effects of the vaccine and reviewed monitoring systems.

Through EpiC, we have also procured and delivered essential medical equipment and supplies to health facilities across the country, supported the development and integration of COVID-19 surveillance data systems into national eHealth programs, and assessed the national diagnostic network to make recommendations for improving laboratory services. EpiC is also supporting the installment of the first liquid oxygen systems, funded by USAID, at major hospitals in Papua New Guinea to improve oxygen availability.